SteadySense

SteadySense is a biomedical engineering company that develops sensor-based continuous temperature measurement systems for medical diagnostics and applications. The company's core technology is a temperature-sensitive sensor embedded in a skin-adhered adhesive patch that continuously measures and records body temperature at predetermined intervals, achieving accuracy of plus or minus 0.1 degrees Celsius. Data is transferred via NFC (Near Field Communication) to compatible smartphones or handheld devices, where it is processed through specially developed iOS and Android apps for visualization and analysis. SteadySense offers three main products: SteadyTemp Professional for early detection of infections in clinical and care settings, SteadyTemp Home for family fever tracking including during sleep, and femSense for determination of ovulation and fertile days in women through detection of post-ovulatory temperature rise, with a birth control feature in development. The company handles all development in-house, from electronics and device drivers to cloud infrastructure and visualization software. Products are ISO 13485 certified and comply with Medical Device Regulation (MDR) standards. The NFC technology ensures low-radiation, contactless data transmission with short reading distances that prevent unauthorized third-party access. SteadySense positions itself as a leader in continuous temperature measurement, serving both the FemTech sector for ovulation detection and the MedTech sector for early infection detection. Founded in 2016 and headquartered in Seiersberg (Raaba-Grambach), Austria, SteadySense has raised $6.7M in Series B funding from investors including EQventure, Auxil, Emc, Situlus Holding, Raiffeisen Bank, Startup Creasphere, and Science Park Graz.